Comment Period Extended to 3/23/2015 for Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
1 study found for:    5768289 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Terminated Alleviation of Cedar Pollen Induced Allergic Symptoms by Orally Taken Superfine Beta-1,3-Glucan
Condition: Allergic Conjunctivitis
Intervention: Drug: beta-1,3-glucan

Indicates status has not been verified in more than two years